TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice

[1]  Zheng-Yu Lin,et al.  Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation. , 2012, European journal of radiology.

[2]  S. Libutti,et al.  Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. , 2012, Journal of vascular and interventional radiology : JVIR.

[3]  P. Robbins,et al.  Preclinical studies for pharmacokinetics and biodistribution of Ad-stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy , 2011, Experimental & Molecular Medicine.

[4]  Hiroyuki Tomita,et al.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.

[5]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[6]  Yong Zeng,et al.  A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria , 2010, Annals of surgery.

[7]  G. Rossi,et al.  Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. , 2010, Cancer research.

[8]  O. Podhajcer,et al.  Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma , 2010, Gene Therapy.

[9]  P. V. van Diest,et al.  Accelerated Perinecrotic Outgrowth of Colorectal Liver Metastases Following Radiofrequency Ablation is a Hypoxia-Driven Phenomenon , 2009, Annals of surgery.

[10]  H. Bear,et al.  Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis , 2009, Breast Cancer Research and Treatment.

[11]  Yan Zhang,et al.  Combined endostatin and TRAIL gene transfer suppresses human hepatocellular carcinoma growth and angiogenesis in nude mice , 2009, Cancer biology & therapy.

[12]  K. Song,et al.  Possible Novel Therapy for Malignant Gliomas with Secretable Trimeric TRAIL , 2009, PloS one.

[13]  G. Shore,et al.  Bcl-2 Proteins and Apoptosis: Choose Your Partner , 2008, Cell.

[14]  Y. Sung,et al.  Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. , 2008, Cancer research.

[15]  K. Mukherjea,et al.  Histological vis – a – vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt – ATP on experimental animal models , 2008, Journal of experimental & clinical cancer research : CR.

[16]  P. Secchiero,et al.  Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand Promotes Migration of Human Bone Marrow Multipotent Stromal Cells , 2008, Stem cells.

[17]  A. Carrato,et al.  Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. , 2007, European journal of cancer.

[18]  P. Robbins,et al.  Cancer gene therapy using a novel secretable trimeric TRAIL , 2006, Gene Therapy.

[19]  J. Haaga,et al.  Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits. , 2005, Radiology.

[20]  P. Flecknell,et al.  Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). , 2005, The Journal of surgical research.

[21]  J. Luk,et al.  Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. , 2005, Journal of immunological methods.

[22]  Guy Marchal,et al.  Local Recurrence After Hepatic Radiofrequency Coagulation: Multivariate Meta-Analysis and Review of Contributing Factors , 2005, Annals of surgery.

[23]  Z. Zhao,et al.  Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro. , 2005, World journal of gastroenterology.

[24]  D. Seol,et al.  The secretable form of trimeric TRAIL, a potent inducer of apoptosis. , 2004, Biochemical and biophysical research communications.

[25]  D. Rockey,et al.  Cell and molecular regulation of endothelin-1 production during hepatic wound healing. , 2003, Molecular biology of the cell.

[26]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[27]  Z. Wang,et al.  Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity , 2001, Nature Medicine.

[28]  I. Bechmann,et al.  Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) , 2000, The Lancet.

[29]  K. Shiraki,et al.  Chemotherapeutic Agents Augment TRAIL‐Induced Apoptosis in Human Hepatocellular Carcinoma Cell Lines , 2000, Hepatology.

[30]  F. Ranelletti,et al.  Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential , 2000, International journal of cancer.

[31]  S. Strom,et al.  Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.

[32]  S. Marsters,et al.  Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.

[33]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[34]  N. Borys,et al.  Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. , 2009, Expert opinion on pharmacotherapy.

[35]  Yong J. Lee,et al.  Effect of hyperthermia and chemotherapeutic agents on TRAIL‐induced cell death in human colon cancer cells , 2008, Journal of cellular biochemistry.

[36]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[37]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.